Resona Asset Management Co. Ltd. Purchases 33,515 Shares of Ventas, Inc. $VTR

Resona Asset Management Co. Ltd. boosted its position in Ventas, Inc. (NYSE:VTR) by 12.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 301,720 shares of the real estate investment trust’s stock after buying an additional 33,515 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in Ventas were worth $24,639,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Deutsche Bank AG grew its holdings in Ventas by 0.7% in the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after buying an additional 27,688 shares during the last quarter. Cbre Investment Management Listed Real Assets LLC lifted its holdings in shares of Ventas by 93.5% during the third quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,750,598 shares of the real estate investment trust’s stock worth $122,524,000 after buying an additional 845,694 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in shares of Ventas during the fourth quarter worth approximately $1,335,000. Elevatus Welath Management acquired a new position in shares of Ventas during the third quarter worth approximately $2,767,000. Finally, Bank of New York Mellon Corp boosted its position in shares of Ventas by 2.5% in the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after acquiring an additional 70,459 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Performance

VTR opened at $91.80 on Friday. The stock has a market cap of $44.63 billion, a PE ratio of 166.91, a P/E/G ratio of 1.99 and a beta of 0.70. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 1 year low of $62.47 and a 1 year high of $94.60. The stock’s 50 day simple moving average is $86.54 and its 200-day simple moving average is $83.61.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts forecast that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. Ventas’s dividend payout ratio is currently 378.18%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on VTR. Barclays assumed coverage on shares of Ventas in a research note on Tuesday. They issued an “equal weight” rating and a $99.00 price objective on the stock. Evercore reiterated an “outperform” rating and set a $95.00 target price on shares of Ventas in a research note on Wednesday, April 29th. Citigroup increased their price target on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. JPMorgan Chase & Co. raised their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $110.00 price objective on shares of Ventas in a report on Tuesday, May 19th. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and an average price target of $96.17.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.